University Briefs

Ninety-nine percent of all gifts to Cornell University for research and education are restricted grants designated for specific purposes. But between 15% and 20% of these awards do not contribute to the university's general expenses, such as maintenance and utilities. In response to this inequity, Cornell University Provost Robert Barker has introduced a policy requiring that a certain percentage of all gifts must go to pay indirect costs, regardless of the donor's specifications. In some cases

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In order to prepare the university's facilities for the policy, Cornell began a trial run July 1, showing on departmental accounts what the deductions would have been if the plan had been in effect. "We're going to discover all its flaws," Barker says, adding that he expects opposition from some donors, who will have to choose between giving more to their favorite departments or having less impact on those departments. With the policy scheduled to go into effect July 1, 1990, Barker expects the university to save up to $3 million per year in indirect costs.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies